Diagnostic HYBRIDS innovates, develops, manufactures and markets cellular and molecular diagnostic kits for various applications in detecting a wide range of respiratory diseases, herpes infections, thyroid function, and other high value markers of disease. DHI products provide an accurate, rapid and cost-effective diagnosis, and their products are changing the way people use technologies to more effectively diagnose and treat respiratory and other diseases. The company strive to address a variety of health issues, impacting the quality of healthcare outcomes and the quality of life.
DHI product profolio:
Diagnostic HYBRIDS is committed to providing quality products and exceptional service to customers through teamwork, regulatory compliance, process control, and continual Quality Management System improvement. The company is certified to ISO 13485 standards, a testament to the quality and care that go into manufacturing and servicing our product lines.
| 
